This page is an unofficial LFoD record and is not legal advice. Verify the document against the official source before relying on it.
HB271: relative to possession and administration of an opioid antagonist for opioid-related overdoses.
Bill details
Version history, amendments, and roll-call votes were not present in the imported local bill data.
Sponsors
- Andrew Bouldin House · Hills 12
- Christopher Herbert House · Hills 43
- Kathleen Hoelzel House · Rock 3
- Burt,�Hills 39 House
- David J. Luneau House · Merr 10
- June Frazer House · Merr 13
- Hatch, Coos�6 House
- Joseph Hannon House · Straf 25
- William Goulette House · Hills 23
- James A Spillane House · Rock 2
- John Reagan Senate · Dist 17
Topics
Official links
CHAPTER 65
HB 271 – FINAL VERSION
18Feb2015… 0112h
2015 SESSION
15-0443
04/01
HOUSE BILL 271
AN ACT relative to possession and administration of an opioid antagonist for opioid-related overdoses.
ANALYSIS
This bill exempts from the provisions of the controlled drug act a health care professional or other person who prescribes, dispenses, distributes, or stores an opioid antagonist, or who administers it to an individual suffering from an apparent opioid-related overdose.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
18Feb2015… 0112h
15-0443
04/01
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Fifteen
AN ACT relative to possession and administration of an opioid antagonist for opioid-related overdoses.
Be it Enacted by the Senate and House of Representatives in General Court convened:
65:1 New Paragraph; Controlled Drug Act; Persons and Corporations Exempted. Amend RSA 318-B:15 by inserting after paragraph III the following new paragraph:
IV.(a) A health care professional authorized to prescribe an opioid antagonist may prescribe, dispense, or distribute, directly or by standing order, an opioid antagonist to a person at risk of experiencing an opioid-related overdose or a family member, friend, or other person in a position to assist a person at risk of experiencing an opioid-related overdose. Any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice.
(b) A person or organization may, if acting pursuant to the provisions of subparagraph (a), store and possess an opioid antagonist, dispense or distribute an opioid antagonist, and administer an opioid antagonist to another person who the person believes is suffering an opioid-related overdose.
(c) No health care professional who, acting in good faith and with reasonable care, prescribes, dispenses, or distributes an opioid antagonist directly or by standing order and no person who, acting in good faith and with reasonable care, stores, dispenses, or distributes an opioid antagonist or administers an opioid antagonist to another person who the person believes is suffering an opioid-related drug overdose shall be subject to any criminal or civil liability, or any professional disciplinary action, for any action authorized by this paragraph or any outcome resulting from an action authorized by this paragraph.
(d) In this paragraph:
(1) “Opioid antagonist” means any drug that binds to opioid receptors and blocks or disinhibits the effects of opioids acting on those receptors.
(2) “Opioid-related drug overdose” means a condition including, but not limited to, extreme physical illness, decreased level of consciousness, respiratory depression, coma, or death resulting from the consumption or use of an opioid, or another substance with which an opioid was combined, or that a layperson would reasonably believe to be an opioid-related drug overdose that requires medical assistance.
65:2 Effective Date. This act shall take effect upon its passage.
Approved: June 2, 2015
Effective Date: June 2, 2015